More Than 65% of Postmenopausal Women Are Affected, Yet Almost No One Speaks About It
Genitourinary symptoms around menopause are often met with silence. Naming the discomfort can open the door to assessment and support.

In this article

The shopping basket in the pharmacy that was not yet full
1. The woman who turned and walked away in the pharmacy
Between the shelves of a chain pharmacy, a woman in her fifties had been standing for quite some time.
She held a slip of paper bearing a few words she had written herself. The writing was small, perhaps deliberately untidy. The shelves contained various topical products: lubricants, moisturizers, and cleansing products, with small print on their packaging and even finer detail in the instructions. She picked up a box, turned it over, looked for a few seconds, and put it back. She picked up another, glanced at the price, and put that back too.
A young assistant approached and politely asked, "What are you looking for? Can I help?"
She said, "I am just looking," folded the paper into her pocket, and turned toward the door. At the entrance she paused, looked back at the shelf, and finally pushed the door open and left.
Later, she might try another shop farther from home, buy online using an anonymous account, or simply give up and endure it for another year, two years, or five.
That departing figure is what this article is really about.

Those unbranded boxes were something she should have been able to ask about
Because here, medicine already offers evidence-based ways to help, and what stops most people is not a medical obstacle but being unable to talk about it.
Over the past year or two, content breaking this silence has emerged on social media abroad. Using straightforward, sometimes rather blunt everyday language, it openly discusses postmenopausal intimate discomfort: painful sex, recurrent urinary tract infections, dryness, burning, and changes in vulvar appearance. A phrase widely circulated in English-speaking spaces compares the vulva with lips: "Save Your Lips." This metaphor places an embarrassing topic in a framework everyone understands and can even smile about.
The reach is clear: a single viral video received close to 2 million views.
Behind it is a striking figure: more than 65% of postmenopausal women experience problems of this kind, yet very few proactively seek medical help.
This article addresses three things: what this condition is, why silence has surrounded it for so long, and what boundary you should maintain when this content begins selling products.
2. Mechanism and background: a problem held back for years by its name
2.1 From "vaginal atrophy" to GSM: a necessary name change
The condition has a relatively new formal medical name: genitourinary syndrome of menopause (GSM). Its earlier common name was "vulvovaginal atrophy."
The reasons for changing the name were practical.
First, the old name was too narrow. "Vulvovaginal atrophy" sounds as if only the vulva and vagina are involved, but the urinary system is affected too. Urethral and bladder symptoms—frequency, urgency, and recurrent urinary tract infections—often arise from the same mechanism. Without "urinary" in the name, many women with repeated infections never consider a connection with menopause. They repeatedly visit urology and use antibiotics, while the underlying issue remains unaddressed.
Second, "atrophy" strongly suggests aging. Although descriptive, to the person hearing it the word often means "I am old, I am no longer capable, this is undignified." This psychological burden is itself an important reason for not seeking care. When a name makes people reluctant to mention a condition, the name is part of the problem.
"Genitourinary syndrome of menopause" restores these changes to being "a condition caused by declining estrogen, involving several sites, and with ways to manage it." It replaces "the shame of aging" with "a medical problem that can be managed." That change matters greatly: it is the first step from "I am too embarrassed to say it" to "this deserves attention."
2.2 Why these changes happen after menopause
Understanding this starts with a fact: the tissues of the vagina, lower urethra, and bladder trigone contain many estrogen receptors.
These tissues are sensitive to estrogen. With normal estrogen levels, the vaginal epithelium retains thickness and elasticity, secretions provide natural lubrication, local pH remains favorable for defense, and blood flow is relatively abundant.
After menopause, substantially lower estrogen causes a series of changes in these areas: thinner epithelium, reduced elasticity, less natural lubrication, altered local pH, and reduced blood flow. These changes produce specific forms of discomfort.
Most importantly, this is a progressive process. Many people notice almost nothing early after menopause and develop symptoms gradually years later. Symptoms tend to worsen over time: this is not something that "gets better once you adapt."
Two further points matter. First, these changes are not "normal aging that must be endured," but a medical condition with a clear cause and management options. "Normal" and "needs attention" do not contradict each other. Second, "paying more attention to hygiene" will not solve it. Excessive cleaning and irritating washes can actually make it worse, as discussed below.
2.3 Symptom checklist: many people do not realize these belong together
Please compare your symptoms with this section, because it explains why many people end up in the wrong specialty.
Manifestations that may share the same mechanism
One: dryness and friction-related discomfort—dryness, tightness, or friction during everyday activities; significant pain during sex, sometimes lasting afterward.
Two: burning or stinging—not necessarily constant, but perhaps occurring during urination or after prolonged sitting.
Three: recurrent urinary tract infections—the easiest connection to miss. Many people repeatedly take antibiotics, improve temporarily, and relapse, without anyone explaining that postmenopausal tissue changes may be involved.
Four: frequency, urgency, or discomfort during urination—symptoms persist even when no definite infection is found.
Five: changes in vulvar appearance and sensation—changes in tissue appearance, the labia minora, or local skin sensation.
Six: avoidance resulting from these symptoms—pain and embarrassment lead to avoiding intimacy, affecting relationships and mood. This is not a "psychological problem" but a natural consequence of the preceding five issues, and often the greatest effect on quality of life.
These manifestations span both gynecology and urology. That is why people may move back and forth between two departments without anyone connecting the whole picture.
A question you can use directly:
If recurrent urinary tract infections or persistent dryness and pain develop after menopause, and repeated urological investigations and treatment have not helped enough,
ask proactively: Could these be related to menopause, and should I have a gynecological assessment?
Many people have never asked that single question.
2.4 Why silence can persist for so many years
This situation is distinctive because the obstacles accumulate in layers.
The first layer is language. Many women lack words to describe it. They know it hurts and feels uncomfortable, but do not know it has a name or is "a medical problem that can be discussed," rather than "only me; I am abnormal."
The second layer is shame. This is the heaviest. Intimate discomfort is highly private in many cultures, and speaking about it is embarrassing. Standing in a pharmacy for ten minutes and then walking away is a typical expression of that obstacle.
The third layer is expectation. Many genuinely believe "this is aging; I should endure it." If someone believes nothing can be done, she will not seek care. This is the layer most easily overlooked and most easily corrected.
The fourth layer is information access. Because asking someone or buying in person feels embarrassing, content and products in this field are naturally more likely to be consumed online. This also sets the scene for the commercial spillover discussed later.
2.5 Its relationship to the menopause conversation: upstream and downstream
Why has this content appeared in the current conversation and gained relative professional approval? Its relationship to the main topic is clear.
The broader menopause discussion answers upstream questions: Why is this happening? What are hormonal changes? Am I entering this stage? Should I address it, and what choices exist?
This content answers downstream questions: Where exactly is the discomfort? Is it common? Do others experience it? What can I do, and which specialty should I see?
Upstream questions readily become broad and abstract, and can develop into the "overdiscussion" described in another article. Downstream questions are concrete and practical, and their direct result is "more people seeking care."
That is why this content gains the greatest professional approval: its direction is toward the clinic, rather than around it.
3. Evidence review: which approaches are reliable, and which are not?
3.1 Why the metaphor "the vulva is like lips" works
The success of this content rests on a clever communication technique worth examining, because it also offers an entry point to accurate understanding.
Comparing the vulva with lips does three things.
It removes the psychological barrier of medicalization. People naturally apply balm to dry, cracked lips without shame. Transferring that mental model to another body part turns the weighty decision "I need to see a doctor" into the lighter recognition "this part of me needs care too."
It offers a functional analogy understandable in daily life. Lips need moisture and intact tissue to feel comfortable; the logic is intuitive.
It provides a way to discuss the issue publicly. A metaphor that can be spoken aloud supplies a shared language for public discussion—the first step in breaking silence, without requiring anyone to overcome shame beforehand.
But metaphors have limits, and this matters: lip balm may be sufficient for cracked lips, but when intimate symptoms arise from tissue changes caused by declining estrogen after menopause, topical moisturizers alone are usually insufficient to address the underlying issue. A doctor needs to assess whether local medication is required. The metaphor opens the conversation; it cannot replace medical judgment.
3.2 An approach with clearer evidence: local estrogen treatment
Among the available approaches, local (vaginal) estrogen therapy has comparatively solid evidence and broad professional acceptance. Common ingredients include estriol and estradiol.
Its characteristics deserve explanation, because they distinguish it from consumer products.
First, it acts locally. It is designed to act on local tissue rather than achieve its effects through systemic absorption, so its scope and risk profile differ from systemic medication, and doses are usually much lower. This explains its widespread use for these symptoms.
Second, it addresses the mechanism. As explained earlier, reduced estrogen in local tissues underlies this set of changes. Supplying estrogen locally addresses that mechanism, rather than merely easing surface symptoms. This is fundamentally different from "using a moisturizer for immediate comfort."
Third, a doctor must decide usage and monitoring. Even for local medication, suitability, formulation, duration, and review intervals depend on your particular history, especially prior cancers. These medicines require a prescription or medical direction; buying and using them independently is not recommended.
Why this approach is well regarded professionally
It targets a defined mechanism, acts locally, has a relatively clear evidence base, and requires medical assessment and follow-up.
It promises neither "a cure" nor "natural harmlessness," but offers an option that can be assessed and followed up.
3.3 Approaches with weak evidence or needing caution: consumer products and devices
This is an area that requires particular emphasis.
Once a topic attracts traffic, commercial spillover is almost inevitable. Related products appearing on social-media shelves over the past year or two broadly fall into these categories:
Vaginal moisturizers and lubricants. Some have genuine uses: they can ease immediate dryness and friction as meaningful adjuncts, providing "symptom relief." But relieving current discomfort and addressing tissue-level changes are different things. The former can be self-purchased; the latter requires assessment. Ingredients also matter, and irritating additives should be avoided.
Various "vaginal health" instruments and devices. Their promotional positioning often sits ambiguously between everyday products and medical devices. Before buying, clarify: What does it claim to do? Is corresponding research available through legitimate channels? Is it regulated as a medical device?
Various "vaginal health" supplements. These commonly claim to improve dryness or local condition. Evidence is often weak, and the proposition that "oral supplements improve estrogen-dependent changes in local tissue" itself needs stronger support.
Laser and energy-based treatments. These are controversial within the professions themselves. Questions concern genuine clinical benefits, how long benefits last, and long-term safety; professional organizations do not agree completely. These options should be discussed after medical assessment in a proper healthcare facility, rather than purchased independently as consumer services.
What you can do yourself
Use adjuncts for immediate comfort, such as moisturizers or lubricants after understanding their ingredients; avoid irritating cleansers and excessive washing; record symptoms for your appointment.
What requires a doctor's assessment
Whether local medication is needed, which one, for how long, and how to follow up; recurrent urinary infection management; suitability of laser or energy-based treatment; and anything requiring a prescription.
3.4 An old belief that needs correcting
Common claim: Washing more and paying attention to hygiene will make this better.
Inaccurate, and potentially harmful. After menopause, local tissue is already more vulnerable and natural defenses weaker. Excessive cleaning and frequent washes or disinfecting products can cause further irritation and discomfort, even making things worse.
The right direction is to reduce irritation, avoid overcleaning, and obtain a formal medical assessment.
Common claim: This inevitably comes with aging; endure it and it will pass.
Inaccurate. These changes have clear physiological causes and assessable management options. They gradually worsen over time and usually do not resolve spontaneously.
This is not "aging that must be endured," but a manageable medical condition.
4. Risks and controversies: boundaries to maintain
4.1 First risk: destigmatization turning into the opposite of seeking care
This is the central issue.
Removing shame should let people who previously could not speak enter a consultation and describe their concerns. If commerce dominates, however, the process can turn in the opposite direction: replacing "you need to see a doctor" with "you need to buy this."
A simple but effective test is where the content ultimately directs its audience. Toward a clinic and "this problem has a name and deserves a medical question" means education; toward a basket, a specific brand, or "no hospital needed; use this" means sales. Both can appear on one account, so assess what that individual piece of content does, not the account's overall identity.
Look for one sentence first
Look for "please see a doctor."
If content about intimate discomfort never mentions "consultation," "doctor," or "assessment," but names more than three products, it is probably mainly selling.
4.2 Second risk: mistaking symptom relief for solving the problem
Moisturizers and lubricants have real value: they improve immediate comfort and make intimacy less painful. That is not a bad thing.
But someone who relies only on them and keeps postponing care because "I can still manage" may miss a chance to address the mechanism. This is the difference between "relief" and "management": relief makes today easier; management changes the course of the coming years.
A more reasonable approach is to use them as adjuncts while arranging formal assessment so a doctor can determine whether further management is needed.
4.3 Third risk: treating recurrent urinary tract infections in isolation
This deserves separate discussion because delay is easy and its costs are practical.
Recurrent urinary tract infection is fairly common after menopause. A usual cycle is to take medicine when infection occurs, stop when it improves, and repeat. After many repetitions, ask: Is an underlying cause being left unaddressed? Postmenopausal changes in local genitourinary tissue are one factor that should be considered.
Raise it proactively. Explain how many infections you have had in the past two years, how each was treated, and whether any gynecological assessment was done. The completeness of the history directly affects whether a doctor considers this connection.
4.4 Fourth risk: effects on relationships and emotions
The effects rarely stop with the body.
Painful sex leads to avoidance, avoidance affects the relationship, relationship changes cause emotional distress, and that distress may be dismissed as "normal mood fluctuations at this age," again missing assessment. This is a typical chain reaction.
Be clear: the chain starts with a physical problem that can be managed after medical assessment. Attributing everything to "relationship issues" or "psychological problems" often takes a longer route. If emotional or relationship distress already significantly affects life, that part also deserves help in its own right. The two do not conflict.
4.5 Fifth risk: thinking "it is too early" after 40
A substantial share of this article's readers are women between 40 and 50 who have not fully reached menopause. For this group, one point needs clarity:
Related symptoms can begin during perimenopause. Because the process is gradual, mild early discomfort is easily attributed to "being tired lately" or "perhaps some inflammation." Waiting until symptoms clearly affect daily life may mean years of unnecessary suffering.
Do not postpone an appointment because "I am not that age yet." Symptoms matter much more than your current age.
5. Practical advice: how to enter the consultation room and speak
This section tackles the most practical issue: turning something hard to mention into an effective appointment.
5.1 First, write it down
Many people are stuck at "I cannot say it." The most effective solution is to write it beforehand and take the paper with you.
A self-recording template you can copy
One: when it began—approximately how long after menopause, or when you first noticed it.
Two: what it feels like—dry, painful, burning, itchy, tight, or uncomfortable with friction. Use your own words; medical terms are unnecessary.
Three: when it worsens—during sex, urination, after prolonged sitting, after exercise, or in a particular season.
Four: whether these also occur—repeated urinary infections (how many and how often), frequency, urgency, discharge changes, or bleeding.
Five: how it affects your life—the most important point. Does it affect sleep or intimacy, make you avoid social activity, or simply leave you continually uncomfortable? Its impact is central to a doctor's judgment about intervention.
Six: what you have tried—which products, their effects, and any adverse effects.
Hand the paper to the doctor and say something simple:
"There are some things I feel embarrassed to say, so I wrote them down. Could you read this?"
That sentence is easy to say and very effective. Doctors deal with these situations daily and will not be surprised or embarrassed by your problem. You only need to say this sentence; the conversation can then move forward.
5.2 Questions to ask during the consultation
Six questions
Could these symptoms be related to postmenopausal changes in local tissue?
Do I need any tests? What conditions need ruling out?
What management options fit my situation? What evidence and risks does each have?
If medication is needed, how long and how should I use it? What monitoring is required, and how often should I return?
Could my recurrent urinary infections be connected, and should they be addressed together?
Which products can I use at home myself, and which decisions require you?
Question 6 is particularly useful. It separates "consumer products" from "medical management" and gives you your own reference point when you encounter related content later.
5.3 Which specialty to see
This is a practical difficulty: symptoms span gynecology and urology, leaving many people unsure which appointment to book.
A practical approach is: if dryness, pain, burning, or vulvar discomfort is the main concern, gynecology is a suitable starting point. If recurrent urinary infections, frequency, or urgency predominate, start with urology, but proactively mention your menopause status and gynecological symptoms.
If possible, a better option is a clinic experienced in menopause-related concerns, because both gynecological and urinary aspects need to be viewed together rather than split in two. You can ask beforehand, "Do you have experience with these postmenopausal problems?" This is not offensive and can help avoid unnecessary detours.

A quiet consultation room: this is where the problem can truly be addressed
5.4 If you still cannot speak
Even with a written note, some people may still be unable to speak in the consultation. That is normal; do not blame yourself.
Several approaches are possible: first, write the problem in the notes when booking online, so the doctor knows in advance what to discuss; second, choose a doctor you find easier to talk to (preferences about gender or age are reasonable); third, start with a consultation in community or primary care, where pressure may be lower and referral can follow if necessary.
One reminder: these problems usually will not disappear if you simply wait longer. The cost of delay is not "enduring it a little longer," but "enduring it for more years."
5.5 Three boundaries when consuming content
You can read it, but keep these three boundaries
One: accept "this is common," and set aside "this product will fix it." The first is the content's most valuable part because it addresses shame; the second needs a doctor's judgment.
Two: distinguish evidence-based medical management from consumer products. Adjuncts for relief can be purchased yourself; prescription approaches need assessment.
Three: unusual symptoms always take priority for medical care. Bleeding, persistent pain, a new lump, or a significant change lie beyond what "health education can cover" and require an appointment.
5.6 If someone you know is stuck here
This last point is for people "reading on someone else's behalf."
Many will not research their own problem but will do so for a mother, sister, or friend. If that is you, several things can help:
First, tell her its name. "Your condition has a name, and it is common; there is nothing wrong with you." This sentence may be worth more than you imagine.
Second, replace the answer "just endure it." Explain that it can be managed and is not aging she must tolerate.
Third, make seeking care easier. Help book, accompany her, or at least help write down what to say. For many, the hardest part is never treatment but walking through that door.
6. Conclusion: removing shame is about entering the consultation room
Return to that pharmacy.
If the woman later encountered this content, something might change. She would learn that the condition has a name, is common, and affects more than six in ten people; that being "unable to say it" is not her personal failing but a widespread situation magnified by years of silence; and that comparing it with lips makes it a little easier to discuss.
All of this has value. It does something important: moves a person from "this is my embarrassment" to "this is a condition that can be managed."
But a further step remains, and it is the one this article most wants to explain: knowing it is common does not mean knowing what to do; daring to discuss it does not mean knowing whom to approach.
Real resolution happens in the consultation room, not on a screen. It requires an assessment, a plan addressing the mechanism, and follow-up.
The reason these discussions abroad have gained relative professional acceptance is simple: their direction is right—they make more people willing to seek care rather than bypass healthcare. This is their fundamental difference from content about "folk remedies," "detoxification," or "self-healing."
This is also the boundary those of us making content must maintain:
Removing shame should lead people into a consultation room, not a shopping livestream.
Break the silence, then guide those reached through that broken silence to the right place. Only then is the whole task complete.
If this article helps one person stop turning away at the pharmacy door and instead pick up her phone to book an appointment, it has done its job.
Main reference sources
· The clinical definition of genitourinary syndrome of menopause (GSM) and the background to replacing the former name "vulvovaginal atrophy" (terminology commonly used internationally in menopause medicine and gynecology)
· Public data on GSM prevalence after menopause (more than 65% affected) and the low proportion proactively seeking care
· Reach of "Save Your Lips" social-media content: everyday metaphors for vulvar discomfort, with a single viral video approaching 2 million views
· Physiological descriptions of estrogen receptors in the vagina, lower urethra, and bladder trigone, and postmenopausal tissue changes
· Evidence and application principles for local (vaginal) estrogen in GSM: local action, a mechanism-based approach, and use with medical assessment and follow-up
· Professional debate over laser and energy-based GSM treatment, with contested evidence and differing organizational positions
· Public discussion of adjunctive relief from vaginal moisturizers and lubricants, and the weaker evidence behind "vaginal health" devices and supplements
· Clinical observations that related manifestations can begin in perimenopause and gradually worsen over time
· Public professional discussion of links between recurrent urinary infection and postmenopausal local genitourinary changes (associations derived largely from observational studies)
This article is health education and does not constitute individualized diagnosis or treatment advice. Choices about investigations, medicines, and other approaches require assessment by the treating doctor based on personal circumstances, including history and relevant risk factors. Seek prompt care for vaginal bleeding, persistent pain, a new lump, or any marked abnormal change. Do not diagnose yourself or purchase and use medication based on online content. No specific drug, brand, product, or institution is recommended.
Sources and review scope
- Editorial author
- Gingera Editorial
- Clinical reviewer
- Not yet assigned
- Citation date check
- Pending; source publication dates are not recorded here.
- Risk note
- High: intimate-health content requires careful terminology and a clear professional-care boundary.
Questions for the clinical reviewer
- Distinguish education from diagnosis.
- Check treatment options, product language and when to seek care.
Report a content issue
This record lists review questions and citations. It does not mean a clinician has reviewed or approved the article.
Published correction log
- Loading correction history…
Read the source material
The original archive manuscript is restored above. These additional references offer context; their inclusion does not constitute medical validation of every original claim. Clinical and regional terminology review are pending.
A good question starts a conversation.
Explore a related editorial discussion. Reading is open to everyone; posting and replying require a free reader account.


